Europe — EMA

Osteogenon (Ossein Hydroxyapatite Compound)

Ossein Hydroxyapatite Compound, the active ingredient in Osteogenon, is a unknown drug class presented as an unknown strength/unknown form for oral use. It is listed without specific therapeutic indications.

Ossein Hydroxyapatite Compound

Request sourcing

Pack/s

What is Ossein Hydroxyapatite Compound?

GNH USA supplies Osteogenon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Ossein Hydroxyapatite Compound used for?

Osteogenon is mentioned as a compound that may be considered in contexts related to bone health and mineral supplementation. Specific : - Bone health support: May contribute to the maintenance of normal bone density . - Calcium‑rehyde re‑ . - Calcium de t . - . - . - . - . - . - . - . - . - . - . - . - . - . - . - . - . - ");

What are the side effects of Ossein Hydroxyapatite Compound?

Osteogen

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →